Premium
Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration.
Author(s) -
Gavey CJ,
Smith JT,
Nwokolo CU,
Pounder RE
Publication year - 1990
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1990.tb03666.x
Subject(s) - gastrin , dosing , clofibrate , medicine , endocrinology , human stomach , chemistry , stomach , enterochromaffin cell , plasma concentration , secretion , serotonin , receptor
1. We studied the effects of acute oral dosing with clofibrate (500 mg four times daily) on 24 h intragastric acidity and plasma gastrin concentration in 12 healthy female subjects. 2. The 24 h integrated intragastric acidity rose from 429 mmol l‐1 h (95% CI 296‐479) before dosing to 527 mmol l‐1 h (95% CI 385‐664) on the day of dosing (+23%; P = 0.041), but no change was observed in the 24 h integrated plasma gastrin concentration: 420 pmol l‐1 h (95% CI 282‐499) before and 389 pmol l‐1 h (95% CI 249‐489) during dosing (P = 0.182). 3. We conclude that clofibrate has no acute antisecretory effect on the human stomach, and that human gastrin‐induced enterochromaffin‐like cell proliferation is unlikely with this drug.